Study of Nab-Paclitaxel in High Risk Early Breast Cancer
Clinical trial NCT01690702 · COMPLETED
Trial details
- NCT number
- NCT01690702
- Sponsor
- GBG Forschungs GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2018-09-30
- Enrollment
- 2886
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.